Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.
about
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines.
P2860
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impact of body weight and miss ...... r doses during late pregnancy.
@ast
Impact of body weight and miss ...... r doses during late pregnancy.
@en
Impact of body weight and miss ...... r doses during late pregnancy.
@nl
type
label
Impact of body weight and miss ...... r doses during late pregnancy.
@ast
Impact of body weight and miss ...... r doses during late pregnancy.
@en
Impact of body weight and miss ...... r doses during late pregnancy.
@nl
prefLabel
Impact of body weight and miss ...... r doses during late pregnancy.
@ast
Impact of body weight and miss ...... r doses during late pregnancy.
@en
Impact of body weight and miss ...... r doses during late pregnancy.
@nl
P2093
P2860
P50
P356
P1476
Impact of body weight and miss ...... r doses during late pregnancy.
@en
P2093
Alice Stek
Aram Limtrakul
Boonsong Rawangban
Brookie M Best
Edmund V Capparelli
Jean-Marc Treluyer
Mark Mirochnick
Prapan Sabsanong
Saik Urien
Sudanee Buranabanjasatean
P2860
P304
P356
10.1093/JAC/DKU367
P407
P577
2014-09-25T00:00:00Z